MetMod-T1D

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1
Diabetes (MetMod-T1D)

A solid, uniform light blue color fills the entire image without any patterns, objects, or text visible.

Study Description

IRB #

STUDY00023975

Principal Investigator

Dr. Petter Bjornstad

Study Location

UW Medicine Diabetes Institute and Prevention Center at Fred Hutchinson Cancer Center

This is a trial testing whether a medication called AMX0035 will help improve metabolism and blood sugar control in adults with Type 1 Diabetes. Participants will take one packet of AMX0035 (mixed with water) twice a day, for 24 weeks. Before starting and after completing the treatment, participants will undergo blood and urine tests, body scans (DEXA and MRI), an insulin sensitivity test, a metabolism test, heart function tests, and
muscle and fat biopsies. While receiving treatment, participants will come in for two in person visits with an ECG to monitor blood tests and side effects, and have one phone call visit.

FAQ MetMod-T1D

Learn more about how you can contribute to important research by volunteering for MetMod-T1D

Who Can Participate?

• Are between the ages of 18 and 70
• Individuals diagnosed with Type 1 Diabetes for at least one year
• HbA1c is less than 9.5%
• Your BMI is between 18.5-40 kg/m2
Page 2 of 2
Version 1.0, dated 13Mar2026
• Must currently be on insulin therapy (multiple daily injections or insulin pump)

Compensation Provided

You will be paid for your time. If you complete all study visits, you will be paid $1,100.00

Contact Study Team

Interested? Complete form below to contact the study team!

Contact Name: Amanda Bard
Phone Number: 504-521-7822
Email: abard@uw.edu

Contact the Study Team - MetMod-T1D

Name(Required)

First Last

Phone(Required)

Email(Required)

Enter Email Confirm Email

Comments(Required)

Preferred Method of Contact (email, phone call, text)